CLINICAL OUTCOME OF VERY REFRACTORY HODGKIN'S LYMPHOMA

被引：0
|
作者：
Gaudio, F. [1 ]
Laddaga, F. E. [1 ]
Laddaga, F. E. [1 ]
Perrone, T. [1 ]
Perrone, T. [1 ]
Pinto, P. [1 ]
Leo, M. [1 ]
Bitetto, C. [1 ]
De Candia, M. S. [1 ]
Ingravallo, G. [2 ]
Pedote, P. [3 ]
Pastore, D. [1 ]
Specchia, G. [1 ]
机构：
[1] Univ Bari, Hematol, Bari, Italy
[2] Univ Bari, Patol, Bari, Italy
[3] Univ Bari, Radiol, Bari, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1776
引用
收藏
页码：704 / 704
页数：1
相关论文
共 50 条
  • [31] Refractory or relapsed Hodgkin lymphoma
    Connors, J
    ANNALS OF ONCOLOGY, 2005, 16 : 40 - 40
  • [32] Relapsed/refractory Hodgkin lymphoma
    Sheikh, Semira
    Kuruvilla, John
    HEMASPHERE, 2018, 2 : 71 - 74
  • [33] The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma
    Kwon, J. M.
    Park, Y. H.
    Kang, J. H.
    Kim, K.
    Ko, Y. H.
    Ryoo, B. Y.
    Lee, S. S.
    Lee, S. I.
    Koo, H. H.
    Kim, W. S.
    ANNALS OF HEMATOLOGY, 2006, 85 (07) : 463 - 468
  • [34] Treatment patterns and clinical outcomes among patients with relapsed/refractory classical Hodgkin's lymphoma
    Nisbett, Alnecia R.
    Yang, Xiaoqin
    Squires, Patrick
    Gautam, Santosh
    Desai, Kaushal
    Raut, Monika
    Nahar, Akash
    FUTURE ONCOLOGY, 2022, 18 (32) : 3623 - 3636
  • [35] Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma
    Mandac, Inga
    Kolonic, Slobodanka Ostojic
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
  • [36] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [37] Efficiency of Nivolumab in Children with Refractory and Relapsed Hodgkin's and Non-Hodgkin's Lymphoma
    Kozlov, A.
    Iukhta, T.
    Gevorgian, A.
    Kazantzev, I.
    Tolkunova, P.
    Tsvetkova, L.
    Morozova, E.
    Lepik, K.
    Mikhailova, N.
    Zubarovskaya, L.
    Afanasyev, B.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S202 - S203
  • [38] Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma
    Inga Mandac
    Slobodanka Ostojic Kolonic
    Journal of Hematology & Oncology, 3
  • [39] Influence of biologic markers on the outcome of Hodgkin's lymphoma:: A study by the Spanish Hodgkin's lymphoma study group
    Montalban, C
    García, JF
    Abraira, V
    González-Camacho, L
    Morente, MM
    Bello, JL
    Conde, E
    Cruz, MA
    García-Sanz, R
    Garcia-Laraña, J
    Grande, C
    Llanos, M
    Martinez, R
    Flores, E
    Méndez, M
    Ponderós, C
    Rayón, C
    Sánchez-Godoy, P
    Zamora, J
    Piris, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) : 1664 - 1673
  • [40] Macrophages predict treatment outcome in Hodgkin's lymphoma
    Steidl, Christian
    Farinha, Pedro
    Gascoyne, Randy D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (02): : 186 - 189
12345